| RITALIN  |
| NAVIGATE |
| News/Information/Articles |
| ||||||||||||||||||||||||||||||||||||
Restoril side effects
| Drug Facts |
|
Many non-medical users crush the tablets and either snort the resulting powder, or dissolve it in water and "cook" it for intravenous injection. Some street names for Ritalin are : Kibbles and bits, speed, west coast, vitamin R, r-ball, smart drug Ritalin is a Schedule II Controlled Substance. Other Schedule II drugs are Oxycontin and Percocet. According to a new DEA report, in some U.S. schools a staggering 30 percent of students are medicated. |
|
Antidepressant Use in Children, Adolescents, and Adults
Food and Drug Administration (FDA) asks manufacturers of all antidepressant drugs to include in their labeling a boxed warning and expanded warning statements that alert health care providers to an increased risk of suicidality (suicidal thinking and behavior) in children and adolescents being treated with these agents, and additional information about the results of pediatric studies.
Current Information
-
FDA Reviews Data for Antidepressant Use in Adults. FDA Talk Paper (7/1/2005)
Public Health Advisory: Suicidality in Adults Being Treated with Antidepressant Medications (issued 6/30/2005) -
Antidepressant Drugs that have Healthcare Professional and Patient Information Sheets (6/30/2005)
-
FDA releases questions and answers concerning the use of the antidepressant drug Effexor (venlafaxine) and the class of antidepressant drugs known as selective serotonin reuptake inhibitors, or SSRIs in adults. Effexor Information (12/7/2004)
-
FDA Launches a Multi-Pronged Strategy to Strengthen Safeguards for Children Treated With Antidepressant Medications. FDA Press Release (issued 10/15/2004)
-
Labeling Change Request Letter for Antidepressant Medications (issued 10/15/2004)
-
Labeling Template (2/3/2005)
-
Medication Guide Template
(2/3/2005)
Background Information
-
September 13-14, 2004, Psychopharmacologic Drugs Advisory Committee, Joint Meeting with the Pediatric Advisory Committee. Meeting Information
-
FDA Statement on Recommendations of the Psychopharmacologic Drugs and Pediatric Advisory Committees (9/16/2004)
-
FDA Updates Its Review of Antidepressant Drugs in Children. FDA Talk Paper (issued 8/20/2004)
-
Public Health Advisory: Suicidality in Children and Adolescents Being Treated With Antidepressant Medications (issued 10/15/2004)
-
Public Health Advisory: Worsening Depression and Suicidality in Patients Being Treated with Antidepressant Medications (issued 3/22/2004)
-
FDA Issues Public Health Advisory on Cautions for Use of Antidepressants in Adults and Children. FDA Talk Paper (issued 3/22/2004)
-
Background Information on the Suicidality Classification Project (issued 3/22/2004)
-
Questions and Answers on Antidepressant Use in Children, Adolescents and Adults (issued 3/22/2004)
-
February 2, 2004, meeting of the Psychopharmacologic Advisory Committee and the Pediatric Subcommittee of the Anti-Infective Drugs Advisory Committee.
Information provided courtesy of www.ritalindeath.com
|
LINK TO US |
|
Show your support. Link to us! 
Click the image above to link to our site! |
|
|
LINKS |
|
|
|
